Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis

Cheng, Ziyu; Li, Zhihui; Gu, Ling; Li, Liqiu; Gao, Qian; Zhang, Xiongfei; Fu, Jin; Guo, Yuanyuan; Li, Qirui; Shen, Xu; Chen, Meijuan; Zhang, Xu

doi:10.7150/jca.66432



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2022; 13(2):715-727. doi:10.7150/jca.66432 This issue Cite

Research Paper

Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis

Ziyu Cheng^1*, Zhihui Li^1*, Ling Gu^1,2, Liqiu Li¹, Qian Gao¹, Xiongfei Zhang¹, Jin Fu¹, Yuanyuan Guo¹, Qirui Li¹, Xu Shen^1✉, Meijuan Chen^1✉, Xu Zhang^1✉

1. School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, People's Republic of China.
2. College of Traditional Chinese Medicine & Integrated Chinese and Western Medicine College, Nanjing University of Chinese Medicine, Nanjing 210023, People's Republic of China.
* These authors have contributed equally to this work.

Citation:

Cheng Z, Li Z, Gu L, Li L, Gao Q, Zhang X, Fu J, Guo Y, Li Q, Shen X, Chen M, Zhang X. Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis. J Cancer 2022; 13(2):715-727. doi:10.7150/jca.66432. https://www.jcancer.org/v13p0715.htm

Other styles

Abstract

Drug resistance has become the main reason for the failure of tumor chemotherapy. Radix Ophiopogon Japonicus has long been used as traditional Chinese medicine to treat pulmonary disease, and Ophiopogonin B (OP-B) as a bioactive component of it has also been verified to inhibit cell proliferation of various non-small cell lung cancer (NSCLC) cells in vivo and in vitro. Therefore, we wonder whether OP-B is also effective to drug resistant lung cancer cells. Firstly, Cell Counting Kit-8 (CCK8) assay was used to compare the sensitivity of OP-B on NCI-H460, A549, cisplatin resistant A549 (A549/DDP) and paclitaxel resistant A549 (A549/PTX) cells, and A549/DDP cells were shown to be more sensitive to OP-B than other three cell lines, the results were further verified in orthotopic tumor nude mice model and zebrafish tumor model. Moreover, observation of cell morphological feature, mitochondrial membrane potential, LDH release rate, and production of IL-1β all suggested that OP-B induced pyroptosis in A549/DDP cells more significantly than that in A549 cells. Meanwhile, transcriptomic sequencing results between OP-B treated and the Mock A549/DDP group also suggested that OP-B induced more significant Caspase-1/GSDMD dependent pyroptosis in A549/DDP group, which was further verified by VX-765, the inhibitor of Caspase-1. Together, the experimental results suggested that OP-B alleviated DDP resistance of A549 cells through inducing more significant Caspase-1/GSDMD-dependent pyroptosis.

Keywords: non-small cell lung cancer (NSCLC) cells, drug resistant, ophiopogonin B (OP-B), pyroptosis, Caspase-1/GSDMD

Citation styles

APA

Cheng, Z., Li, Z., Gu, L., Li, L., Gao, Q., Zhang, X., Fu, J., Guo, Y., Li, Q., Shen, X., Chen, M., Zhang, X. (2022). Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis. Journal of Cancer, 13(2), 715-727. https://doi.org/10.7150/jca.66432.

ACS

Cheng, Z.; Li, Z.; Gu, L.; Li, L.; Gao, Q.; Zhang, X.; Fu, J.; Guo, Y.; Li, Q.; Shen, X.; Chen, M.; Zhang, X. Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis. J. Cancer 2022, 13 (2), 715-727. DOI: 10.7150/jca.66432.

NLM

CSE

Cheng Z, Li Z, Gu L, Li L, Gao Q, Zhang X, Fu J, Guo Y, Li Q, Shen X, Chen M, Zhang X. 2022. Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis. J Cancer. 13(2):715-727.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.